ClinConnect ClinConnect Logo
Search / Trial NCT07026617

Low Level Laser Therapy and Rocabado's Approach for Myogenic TMJ Disorders

Launched by CAIRO UNIVERSITY · Jun 10, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether adding a special type of light treatment called low level laser therapy (LLLT) to a set of jaw exercises (known as Rocabado's 6x6 exercises) can better help people who have muscle-related problems with their jaw joint, called myogenic temporomandibular joint (TMJ) disorders. These exercises aim to relax tight muscles, improve jaw movement, and reduce pain. The laser treatment may help reduce inflammation and pain as well. This study is the first to test if combining these two treatments works better than exercises alone.

People who might be eligible to join are adults between 18 and 40 years old who have had jaw pain or difficulty moving their jaw for at least three months, and who have limited mouth opening (less than 25 millimeters). Participants should not have had recent jaw surgery, fractures, certain joint diseases, or recent dental treatments like braces or dentures fitted within the last three months. If chosen, participants will receive either the combined treatment or a placebo (fake) laser in a carefully controlled way, and their progress will be closely monitored to see how well the treatments work. This study is not yet recruiting, but if you qualify, it offers a chance to try a promising approach for relieving jaw muscle pain and improving jaw function.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • (1) The patient's ages ranged from 18 to 40 years ; (2) having symptoms of TMD for at least twelve weeks duration established by expert physician or orthopaedician; (3) mouth opening \< 25mm
  • Exclusion Criteria:
  • (1) TMJ fracture undergone any surgical procedure for TMJ; (2) Fracture surrounding TMJ; (3) Dislocation or subluxation of TMJ; (4) Systemic generalized joint diseases, such as rheumatoid arthritis, and osteoporosis, congenital diseases or facial paralysis; (5) recently any dental treatment taken or surgery over TMJ; (6) Hematological cervical disorders which may affect the jaw; (7) Neurological deficits e.g. Bells palsy, Trigeminal neuralgia; (8) Recent infections (within the last six months) affecting the head and neck e.g. bone infections, meningitis, encephalitis, malaria, ear infection; (9) Participants who were using any functional appliances e.g. dentures, braces, bite appliances which had been adjusted or fitted in the last 12 weeks prior to the commencement of this study.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported